MacroZyme Overview

  • Founded
  • 2001
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

MacroZyme General Information

Description

Developer of proprietary compounds for treatment purposes. The company focuses on the development of proprietary compounds for the treatment of diabetes, inflammatory disorders and lysosomal storage diseases. The company spun out of the Academic Medical Center.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Meibergdreef 45
  • 1105 BA Amsterdam
  • Netherlands
+31 020 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MacroZyme Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 29-Nov-2005 Completed
1. Early Stage VC Completed
To view MacroZyme’s complete valuation and funding history, request access »

MacroZyme Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MedSciences Capital Venture Capital Minority 000 0000 000000 0
To view MacroZyme’s complete investors history, request access »